Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Role of CHD5 in human cancers: 10 years later.

Kolla V, Zhuang T, Higashi M, Naraparaju K, Brodeur GM.

Cancer Res. 2014 Feb 1;74(3):652-8. doi: 10.1158/0008-5472.CAN-13-3056. Epub 2014 Jan 13. Review.

2.

Chromodomain helicase DNA binding protein 5 plays a tumor suppressor role in human breast cancer.

Wu X, Zhu Z, Li W, Fu X, Su D, Fu L, Zhang Z, Luo A, Sun X, Fu L, Dong JT.

Breast Cancer Res. 2012 May 8;14(3):R73.

3.

Mechanisms of CHD5 Inactivation in neuroblastomas.

Koyama H, Zhuang T, Light JE, Kolla V, Higashi M, McGrady PW, London WB, Brodeur GM.

Clin Cancer Res. 2012 Mar 15;18(6):1588-97. doi: 10.1158/1078-0432.CCR-11-2644. Epub 2012 Jan 31.

4.

CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas.

Fujita T, Igarashi J, Okawa ER, Gotoh T, Manne J, Kolla V, Kim J, Zhao H, Pawel BR, London WB, Maris JM, White PS, Brodeur GM.

J Natl Cancer Inst. 2008 Jul 2;100(13):940-9. doi: 10.1093/jnci/djn176. Epub 2008 Jun 24.

5.

CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system.

Thompson PM, Gotoh T, Kok M, White PS, Brodeur GM.

Oncogene. 2003 Feb 20;22(7):1002-11.

PMID:
12592387
6.

Mutation and methylation analysis of the chromodomain-helicase-DNA binding 5 gene in ovarian cancer.

Gorringe KL, Choong DY, Williams LH, Ramakrishna M, Sridhar A, Qiu W, Bearfoot JL, Campbell IG.

Neoplasia. 2008 Nov;10(11):1253-8.

7.

CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.

Zhao R, Wang N, Huang H, Ma W, Yan Q.

Liver Int. 2014 Jul;34(6):e151-60. doi: 10.1111/liv.12503. Epub 2014 Mar 15.

PMID:
24529164
8.
9.

CHD5 is down-regulated through promoter hypermethylation in gastric cancer.

Wang X, Lau KK, So LK, Lam YW.

J Biomed Sci. 2009 Oct 19;16:95. doi: 10.1186/1423-0127-16-95.

10.

MicroRNA-211 expression promotes colorectal cancer cell growth in vitro and in vivo by targeting tumor suppressor CHD5.

Cai C, Ashktorab H, Pang X, Zhao Y, Sha W, Liu Y, Gu X.

PLoS One. 2012;7(1):e29750. doi: 10.1371/journal.pone.0029750. Epub 2012 Jan 3.

11.

Chromatin remodeling factor CHD5 is silenced by promoter CpG island hypermethylation in human cancer.

Mulero-Navarro S, Esteller M.

Epigenetics. 2008 Jul-Aug;3(4):210-5. Epub 2008 Jul 16.

PMID:
18698156
12.

The tumour suppressor CHD5 forms a NuRD-type chromatin remodelling complex.

Kolla V, Naraparaju K, Zhuang T, Higashi M, Kolla S, Blobel GA, Brodeur GM.

Biochem J. 2015 Jun 1;468(2):345-52. doi: 10.1042/BJ20150030.

13.

The chromatin remodeling factor CHD5 is a transcriptional repressor of WEE1.

Quan J, Adelmant G, Marto JA, Look AT, Yusufzai T.

PLoS One. 2014 Sep 23;9(9):e108066. doi: 10.1371/journal.pone.0108066. eCollection 2014.

14.

Epigenetic silencing of CHD5, a novel tumor-suppressor gene, occurs in early colorectal cancer stages.

Fatemi M, Paul TA, Brodeur GM, Shokrani B, Brim H, Ashktorab H.

Cancer. 2014 Jan 15;120(2):172-80. doi: 10.1002/cncr.28316. Epub 2013 Nov 14.

15.

CHD5 is a potential tumor suppressor in non small cell lung cancer (NSCLC).

Baykara O, Tansarikaya M, Bulut P, Demirkaya A, Buyru N.

Gene. 2017 Jun 30;618:65-68. doi: 10.1016/j.gene.2017.04.010. Epub 2017 Apr 8.

PMID:
28400267
16.

Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma.

Higashi M, Kolla V, Iyer R, Naraparaju K, Zhuang T, Kolla S, Brodeur GM.

Mol Cancer. 2015 Aug 7;14:150. doi: 10.1186/s12943-015-0425-y.

17.

Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma.

Garcia I, Mayol G, Rodríguez E, Suñol M, Gershon TR, Ríos J, Cheung NK, Kieran MW, George RE, Perez-Atayde AR, Casala C, Galván P, de Torres C, Mora J, Lavarino C.

Mol Cancer. 2010 Oct 15;9:277. doi: 10.1186/1476-4598-9-277.

18.

CHD5 is a tumor suppressor at human 1p36.

Bagchi A, Papazoglu C, Wu Y, Capurso D, Brodt M, Francis D, Bredel M, Vogel H, Mills AA.

Cell. 2007 Feb 9;128(3):459-75.

19.

Chd5 requires PHD-mediated histone 3 binding for tumor suppression.

Paul S, Kuo A, Schalch T, Vogel H, Joshua-Tor L, McCombie WR, Gozani O, Hammell M, Mills AA.

Cell Rep. 2013 Jan 31;3(1):92-102. doi: 10.1016/j.celrep.2012.12.009. Epub 2013 Jan 10.

20.

CHD5, a tumor suppressor that is epigenetically silenced in lung cancer.

Zhao R, Yan Q, Lv J, Huang H, Zheng W, Zhang B, Ma W.

Lung Cancer. 2012 Jun;76(3):324-31. doi: 10.1016/j.lungcan.2011.11.019. Epub 2011 Dec 18.

PMID:
22186629

Supplemental Content

Support Center